Literature DB >> 2788377

An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue.

F J Wallace1, R L Clancy, A W Cripps.   

Abstract

An animal model of the clearance of nontypable Haemophilus influenzae has been developed to determine both optimal immunization strategies for controlling colonization of the respiratory tract in patients with damaged airways and mechanisms of action of immune clearance. It was demonstrated that stimulation of gut-associated lymphoid tissue (GALT) (either by direct injection or by ingestion of antigen) followed by local administration of antigen into the bronchus was required to enhance clearance in this model. The primary effect of GALT immunization persisted for at least 6 wk; it was specific and could not be replaced by systemic immunization. Failure to stimulate locally in the bronchus was associated with protracted clearance. No clear correlation between local or systemic antibody and bacterial clearance was demonstrated; however, immunized rats were shown to have faster recruitment of phagocytic cells to the bronchial spaces, and these phagocytes had a higher activity state than cells harvested from nonimmunized animals. It is probable that bacterial clearance is accelerated in immunized animals due in part to factors mediating a change in the behavior of luminal phagocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788377     DOI: 10.1164/ajrccm/140.2.311

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  23 in total

1.  Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein.

Authors:  W El-Adhami; J M Kyd; D A Bastin; A W Cripps
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.

Authors:  D C Webb; A W Cripps
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Cellular changes in the bronchoalveolar lavage (BAL) of pigs, following immunization by the enteral or respiratory route.

Authors:  S Delventhal; A Hensel; K Petzoldt; R Pabst
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

4.  Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model.

Authors:  J M Kyd; A W Cripps
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.

Authors:  A Thakur; J Kyd; M Xue; M D Willcox; A Cripps
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.

Authors:  A Buret; M L Dunkley; G Pang; R L Clancy; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae.

Authors:  J M Kyd; D Taylor; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Immune selection for antigenic drift of major outer membrane protein P2 of Haemophilus influenzae during persistence in subcutaneous tissue cages in rabbits.

Authors:  L Vogel; B Duim; F Geluk; P Eijk; H Jansen; J Dankert; L vanAlphen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  A role for intestinal T lymphocytes in bronchus mucosal immunity.

Authors:  F J Wallace; A W Cripps; R L Clancy; A J Husband; C S Witt
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

Review 10.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.